Search


Biotech CEO Sisterhood: Katherine Stueland describes joining GeneDx as a first time CEO during a turbulent time and reshaping it into a leader in genetic testing for rare disease diagnosis
Interviewed by the Sisterhood Editorial Board Chair Abbey Jenkins, Katherine Stueland describes how the mission of getting the company on stable ground through financial discipline and a sharper focus on strategy has enabled it to thrive and deliver on its mission for patients. Plus, her advice to others having gone through it as a first time CEO. Biographies Katherine Stueland has dedicated her career to transforming healthcare by leading patient-centric businesses. Her care
8 hours ago







.png)